BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17596313)

  • 1. Gag influences transformation by Abelson murine leukemia virus and suppresses nuclear localization of the v-Abl protein.
    Yi CR; Rosenberg N
    J Virol; 2007 Sep; 81(17):9461-8. PubMed ID: 17596313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations affecting the MA portion of the v-Abl protein reveal a conserved role of Gag in Abelson murine leukemia virus (MLV) and Moloney MLV.
    Yi CR; Rosenberg N
    J Virol; 2008 Jun; 82(11):5307-15. PubMed ID: 18367522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extreme carboxyl terminus of v-Abl is required for lymphoid cell transformation by Abelson virus.
    Warren D; Griffin DS; Mainville C; Rosenberg N
    J Virol; 2003 Apr; 77(8):4617-25. PubMed ID: 12663768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The carboxyl terminus of v-Abl protein can augment SH2 domain function.
    Warren D; Heilpern AJ; Berg K; Rosenberg N
    J Virol; 2000 May; 74(10):4495-504. PubMed ID: 10775585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temperature-sensitive transformation by an Abelson virus mutant encoding an altered SH2 domain.
    Mainville CA; Parmar K; Unnikrishnan I; Gong L; Raffel GD; Rosenberg N
    J Virol; 2001 Feb; 75(4):1816-23. PubMed ID: 11160680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-7 reconstitutes multiple aspects of v-Abl-mediated signaling.
    Banerjee A; Rothman P
    J Immunol; 1998 Nov; 161(9):4611-7. PubMed ID: 9794389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of p53 complements defects in Abelson murine leukemia virus signaling.
    Unnikrishnan I; Rosenberg N
    J Virol; 2003 Jun; 77(11):6208-15. PubMed ID: 12743277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the Shc/Grb2 complex during abelson virus transformation affects proliferation, but not apoptosis.
    Baughn LB; Rosenberg N
    J Virol; 2005 Feb; 79(4):2325-34. PubMed ID: 15681433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gag-derived but not abl-derived determinants are exposed on the surface of Abelson virus-transformed cells.
    Schiff-Maker L; Rosenberg N
    Virology; 1986 Oct; 154(2):286-301. PubMed ID: 3020782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts.
    Daley GQ; McLaughlin J; Witte ON; Baltimore D
    Science; 1987 Jul; 237(4814):532-5. PubMed ID: 2440107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insertional mutagenesis of the Abelson murine leukemia virus genome: identification of mutants with altered kinase activity and defective transformation ability.
    Rees-Jones RW; Goff SP
    J Virol; 1988 Mar; 62(3):978-86. PubMed ID: 2828693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ras complements the carboxyl terminus of v-Abl protein in lymphoid transformation.
    Parmar K; Rosenberg N
    J Virol; 1996 Feb; 70(2):1009-15. PubMed ID: 8551558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A membrane-associated, carbohydrate-modified form of the v-abl protein that cannot be phosphorylated in vivo or in vitro.
    Watanabe SM; Rosenberg NE; Witte ON
    J Virol; 1984 Sep; 51(3):620-7. PubMed ID: 6088787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein stabilization explains the gag requirement for transformation of lymphoid cells by Abelson murine leukemia virus.
    Prywes R; Hoag J; Rosenberg N; Baltimore D
    J Virol; 1985 Apr; 54(1):123-32. PubMed ID: 2983109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation within the kinase domain of v-abl gene responsible for temperature-sensitive colony-forming ability in soft agar.
    Soma T; Tsukada S; Oka Y; Kishimoto T; Sugiyama H
    Virology; 1993 Apr; 193(2):967-70. PubMed ID: 8460498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active Akt and functional p53 modulate apoptosis in Abelson virus-transformed pre-B cells.
    Gong L; Unnikrishnan I; Raghavan A; Parmar K; Rosenberg N
    J Virol; 2004 Feb; 78(4):1636-44. PubMed ID: 14747529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain.
    Mysliwiec T; Perego R; Kruh GD
    Oncogene; 1996 Feb; 12(3):631-40. PubMed ID: 8637720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 deficiency increases transformation by v-Abl and rescues the ability of a C-terminally truncated v-Abl mutant to induce pre-B lymphoma in vivo.
    Zou X; Cong F; Coutts M; Cattoretti G; Goff SP; Calame K
    Mol Cell Biol; 2000 Jan; 20(2):628-33. PubMed ID: 10611241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of v-Fgr myristoylation and the Gag domain in membrane binding and cellular transformation.
    Baker SJ; Cosenza SC; Reddy EP
    Virology; 1998 Sep; 249(1):1-11. PubMed ID: 9740771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation.
    Prywes R; Foulkes JG; Rosenberg N; Baltimore D
    Cell; 1983 Sep; 34(2):569-79. PubMed ID: 6193890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.